Merck KGaA

Emboldened by recent R&D successes, Merck KGaA looks at selling off $1B-plus consumer division
Endpoints
Tue, 09/5/17 - 11:06 am
R&D
Merck KGaA
consumer health
M&A
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fri, 09/1/17 - 11:08 am
Fresenius
Merck KGaA
biosimilars
M&A
After a long, painful revamp, Merck KGaA scores key OK for once-defunct MS drug cladribine
Endpoints
Fri, 08/25/17 - 09:57 am
Merck KGaA
MS
multiple sclerosis
cladribine
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
Merck Ventures leads $11M round in solid tumor startup
Fierce Biotech
Wed, 05/31/17 - 11:07 pm
Merck Ventures
Merck
solid tumors
Inthera Bioscience
Merck KGaA
Merck KGaA Edges Full-Year Guidance Higher After Solid Q1 Earnings
Yahoo/TheStreet.com
Thu, 05/18/17 - 09:44 am
Merck KGaA
earnings
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Pfizer
Merck KGaA
AstraZeneca
Bavencio
avelumab
bladder cancer
Imfinzi
FDA
Opdivo
Tecentriq
Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
BioPharma Dive
Sun, 03/26/17 - 12:00 pm
Pfizer
Merck KGaA
Bavencio
avelumab
FDA approves Pfizer, German Merck immunotherapy for skin cancer
Yahoo/Reuters
Fri, 03/24/17 - 09:38 am
FDA
Pfizer
Merck KGaA
skin cancer
metastatic Merkel cell carcinoma
avelumab
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Investopedia
Mon, 03/20/17 - 10:54 am
Pfizer
Merck KGaA
clinical trials
avelumab
non-small cell lung cancer
Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms
Endpoints
Thu, 03/9/17 - 11:36 am
Merck KGaA
biosimilars
M&A
R&D
Merck KGaA, Pfizer get priority review for bladder cancer drug
Yahoo/Reuters
Tue, 02/28/17 - 10:22 am
Merck KGaA
Pfizer
bladder cancer
avelumab
German Merck, Pfizer get FDA priority review for cancer drug
Yahoo/Reuters
Tue, 11/29/16 - 09:55 am
Merck KGaA
Pfizer
FDA
Merkel cell carcinoma
skin cancer
avelumab
Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales
TheStreet.com
Tue, 11/15/16 - 09:33 am
Merck KGaA
earnings
Did Merck KGaA’s aging atacicept just fail a PhIIb lupus trial? Well, yes, but…
Endpoints
Mon, 11/14/16 - 11:16 am
Merck KGaA
atacicept
lupus
clinical trials
Merck KGaA, Pfizer and Transgene team up on cancer vaccine
BioPharma Dive
Wed, 10/12/16 - 11:18 pm
Merck KGaA
Pfizer
Transgene
vaccines
TG40001
HPV head and neck cancer
Merck KGaA Publishes First International Curiosity Study
Yahoo
Wed, 10/12/16 - 11:30 am
Merck KGaA
curiosity
pharma employees
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Motley Fool
Tue, 09/27/16 - 10:51 am
Pfizer
Medivation
Xtandi
avelumab
Merck KGaA
Ibrance
Pfizer, Germany's Merck begin large ovarian cancer trial
Yahoo/Reuters
Thu, 07/7/16 - 09:25 am
Pfizer
Merck KGaA
avelumab
ovarian cancer
Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results
BioPharma Dive
Fri, 05/20/16 - 10:28 am
Merck KGaA
Pfizer
PD-L1
Merkel cell carcinoma

Pages